Jian Yang | Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Jian Yang | Neuroscience | Best Researcher Award

Jian Yang, Ph.D., is an Associate Professor at the School of Medicine, Shanghai University. He holds a B.S. in Chemical Technology and Engineering from Jiangsu Ocean University, an M.S. in Applied Chemistry from Sichuan University, and a Ph.D. in Medicinal Chemistry from China Pharmaceutical University, with joint research training at Massachusetts General Hospital and Harvard Medical School. His research focuses on molecular imaging probe design for early diagnosis of neurodegenerative diseases, PET tracer synthesis, and drug discovery. Dr. Yang has received funding from the China Postdoctoral Science Foundation, the National Natural Science Foundation of China, and the Natural Science Foundation of Shanghai. He actively serves as an editor and reviewer for several international journals.

Assoc. Prof. Dr. Jian Yang | Shanghai University | China

Profile

🎓Education

  • Jian Yang received his Bachelor of Science degree in Chemical Technology and Engineering from Jiangsu Ocean University, Jiangsu, China, in 2003. He pursued his Master of Science in Applied Chemistry at Sichuan University, graduating in 2006. He then completed his Ph.D. in Medicinal Chemistry at China Pharmaceutical University in 2017. During his doctoral studies, he also conducted joint research in Molecular Imaging at Massachusetts General Hospital and Harvard Medical School from 2015 to 2017.

👨‍🏫 Experience

  • Currently, Jian Yang serves as an Associate Professor at the School of Medicine, Shanghai University, a position he has held since September 2020. Prior to this, he worked as a Postdoctoral Fellow at China Pharmaceutical University from 2017 to 2020. Earlier in his career, he held industrial roles, including Manager at Nanjing JoyMed Pharmaceutical Co., Ltd. from 2010 to 2013, Group Leader at Nanjing Acesys Pharmaceutical Co., Ltd. from 2007 to 2010, and Scientist I at WuXi Apptec in Shanghai from 2006 to 2007.

🤝 Awards

  • Jian Yang has been recognized with several research grants and funding awards. These include support from the 62nd China Postdoctoral Science Foundation (No. 1600010008), the National Natural Science Foundation of China (No. 81971677), and the Natural Science Foundation of Shanghai (No. 22ZR1424400).

💡Skills and Certifications

  • He has extensive skills in molecular imaging, PET tracer synthesis, drug discovery, and new imaging technology development. Jian Yang is actively involved in editorial work, serving as a Guest Associate Editor for Frontiers in Bioengineering and Biotechnology and Frontiers in Immunology, Review Editor for Frontiers in Chemistry, and Contributing Editor for Brain-X. He also reviews for several leading journals including Analytical Chemistry, Theranostics, ACS Applied Materials & Interfaces, and Chemical Engineering Journal.

🔬 Research Focus

  • Jian Yang’s research mainly focuses on the design of molecular imaging probes for the early diagnosis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). He is dedicated to advancing new imaging technologies, synthesizing novel PET tracers for preclinical AD studies, and contributing to drug synthesis and drug discovery research.

🌎Conclusion

  • Dr. Jian Yang is highly suitable for the Research for Best Researcher Award. His multi-disciplinary excellence, global collaboration, translational research outcomes, and sustained publication and funding record make him a standout candidate. His contributions not only advance the scientific understanding of brain diseases but also inspire innovation in molecular diagnostics and therapeutics.

📖Publications

  •  Novel Dual-Functional Half-Curcumin Analogues as a Fluorescent and PET Probe for β-Amyloid Imaging in the Alzheimer’s Disease APP/PS1 Model
    Authors: Haijun Yang, Ke Li, Tingfang Wang, Jianguo Lin, Jian Yang
    Journal: ACS Chemical Neuroscience, 2025
  • Dual Targeting of Neuropilin-1 and Glucose Transporter for Efficient Fluorescence Imaging of Cancer
    Authors: Jianwei Zhu, Can Zhou, Jian Yang, Zhenhua Wang
    Journal: Molecular Imaging and Biology, 2025
  • Targeted Radionuclide Therapy of CLDN18.2-Positive Gastric Cancer with [131I]I-Zolbetuximab: An In Vitro and In Vivo Study
    Authors: Yang Wang, Shuhua He, Lin Ma, Zheng Li, Qingnuan Li
    Journal: Molecular Pharmaceutics, 2025

Dr. Rui Sun | Neuroscience | Best Researcher Award

Dr. Rui Sun | Neuroscience | Best Researcher Award

Sun Rui is a Ph.D. student at Zhejiang University, specializing in the intersection of neuroscience and biomedical engineering. His research focuses on the neural mechanisms of mood disorders, exploring brain electrical signals and their role in emotional abnormalities. Utilizing advanced techniques such as microscopy imaging, circuit tracing, electrophysiological recordings, and machine learning, he investigates neural activity patterns and functional changes associated with affective disorders. With a strong interdisciplinary background from the School of Medicine and the Department of Biomedical Engineering, Sun Rui aims to advance our understanding of emotional pathogenesis and develop innovative therapeutic approaches.

Dr. Rui Sun | zhejiang university | China

Profile

SCOPUS  ID

🎓 Education

  • Sun Rui is currently pursuing a Ph.D. at Zhejiang University. He spent the initial three years of his doctoral studies at the School of Medicine, where he focused on the neural mechanisms underlying mood disorders. Later, he transitioned to the Department of Biomedical Engineering, seeking to bridge the fields of engineering and biomedical sciences.

💼 Experience

  • Sun Rui’s academic journey encompasses diverse interdisciplinary expertise. During his time at the School of Medicine, he conducted in-depth research on affective disorders, combining neuroscience and behavioral science. His transition to Biomedical Engineering has further expanded his skillset, enabling him to approach complex biomedical challenges with engineering principles and methodologies.

 🏆 Honors and Awards

  • Throughout his academic career, Sun Rui has been recognized for his innovative approach to neuroscience and engineering. His research contributions have earned accolades at multiple academic conferences and institutional forums.

🛠️ Skills and Certifications

  • Sun Rui is proficient in a variety of advanced techniques, including animal behavioral experiments, microscopy imaging, circuit tracing, multichannel in vivo electrophysiological recordings, and machine learning applications. He also excels in neural network analysis to interpret complex brain activity patterns.

🔬 Research Focus

  • Sun Rui’s research investigates the differences in brain electrical signals associated with emotional abnormalities and their underlying pathogenesis. By integrating cutting-edge techniques such as animal behavioral experiments, imaging, and electrophysiological recordings with machine learning, he explores the neural activity patterns and functional changes linked to affective disorders. His interdisciplinary approach aims to uncover novel insights into the mechanisms driving mood disorders and develop innovative strategies for intervention.

Conclusion

  • Sun Rui is a strong candidate for the Research for Best Researcher Award due to his significant contributions to understanding mood disorders through advanced neuroengineering techniques. Emphasizing his academic achievements through publications, collaborations, and translational outcomes would further strengthen his case for the award.

📄Publications

  • C3aR in the medial prefrontal cortex modulates the susceptibility to LPS-induced depressive-like behaviors through glutamatergic neuronal excitability
    Authors: Sun, R., Tang, M.-Y., Yang, D., Li, X.-M., Lian, H.
    Journal: Progress in Neurobiology, 2024, 236, 102614
  • The dorsal hippocampal CA3 regulates spatial reference memory through the CtBP2/GluR2 pathway
    Authors: Han, J.-X., Wen, C.-X., Sun, R., Li, X.-M., Lian, H.
    Journal: FASEB Journal, 2022, 36(9), e22456
  • ErbB4 regulate extracellular dopamine through the p38 MAPK signaling pathway
    Authors: Cao, S.-X., Wen, C.-X., Sun, R., Li, X.-M., Lian, H.
    Journal: Neuroscience Letters, 2021, 751, 135830